63 results
Page 3 of 4
8-K
EX-99.1
bjg1so0jx3bxnykca8
6 May 20
Axcella Announces Positive Top-Line Data from AXA1125-003 Clinical Study Showing Multifactorial Activity in Adult Subjects with NAFLD
8:09am
DEFA14A
1wswivyz hfj7n1r
3 Apr 20
Additional proxy soliciting materials
4:19pm
DEF 14A
iano8d
3 Apr 20
Definitive proxy
4:15pm
DRS
0w18vv6dw4 g5s
3 Apr 20
Draft registration statement
12:00am
10-K
s26lkl9n25toq0
23 Mar 20
Annual report
4:12pm
8-K
EX-10.1
3dybnl ezn
25 Nov 19
Axcella Strengthens Executive Team with Key Addition and Promotion
8:11am
10-Q
p6lqh54
20 Jun 19
Quarterly report
5:03pm
424B4
4tl j6bt4l4m
9 May 19
Prospectus supplement with pricing info
4:29pm
S-1/A
12xuu
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
EX-10.2
mytf2ubigv
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
EX-1.1
8fiucsi2
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
EX-10.10
n7bmb7116a9d32v z9i
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
EX-10.12
14mfsx6
30 Apr 19
IPO registration (amended)
6:06am
CORRESP
gq93 9js31bh
24 Apr 19
Correspondence with SEC
12:00am
S-1
EX-4.2
ypfvek
12 Apr 19
IPO registration
7:02am